The oxime 1, 1′-methylenebis [4 - [(hydroxyimino) methyl] - pyridinium] dibromide, or MMB-4, appears to be more effective against a broader range of nerve agents than is 2-PAM and will replace 2-PAM for US military use in the next few years.